德英生物科技
Research & Development

Clinical progress and government subsidy programs

Ongoing Clinical Trials

Project Hospital Physician Status
Phase II Open-label Clinical Evaluation of SR-T100 Gel for the Treatment of Cutaneous Squamous Cell Carcinoma (Actinic Keratosis and Bowen's Disease) National Cheng Kung University Hospital Department of Dermatology
Prof. Hsiu-Han Ming
Completed
Pilot Clinical Trial to Evaluate the Official Safety and Non-specific Outcomes of a Commercial Herbal Product, Xu Jian, for Non-small Cell Lung Cancer Patients National Cheng Kung University Hospital Department of Hematology and Oncology
Prof. Wu-Chou Su
Closed
Plant Candidate Drug SR-T100 (Renamed SR-T200) for the Treatment of Pre-cancerous Lesions of the Vulva and Skin Diseases: Efficacy and Safety Evaluation National Cheng Kung University Hospital Department of Obstetrics and Gynecology
Prof. Keng-Fu Hsu
Ongoing
Randomized, Double-blind, Parallel, Vehicle-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Actinic Keratosis National Cheng Kung University Hospital
Chimei Hospital
Kaohsiung Medical University
Chang Gung Memorial Hospital Kaohsiung Branch
Veterans General Hospital Kaohsiung Branch
Department of Dermatology
Prof. Hsiu-Han Ming
Completed